Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC for Recurrent Pregnancy Loss
NCT05520112Phase 2Unknown
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in recurrent pregnancy loss (RPL), endometrial hyperplasia (EH). Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
recurrent pregnancy loss (RPL)endometrial hyperplasia (EH)
Beyond the preview
Go deeper on NCT05520112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05520112.